CompletedNCT00345176
Age-Related Eye Disease Study 2 (AREDS2)
PHASE3 · 4,203 planned enrolment
- Countries listed
- 1
- Registry update
- May 5, 2015
immortal.lifeTrial registrations containing the exact intervention label DHA/EPA.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE3 · 4,203 planned enrolment
PHASE4 · 150 planned enrolment